Review
Using biochemical markers of bone turnover in clinical practice
Frederick R. Singer, MD and David R. Eyre, PhD
Cleveland Clinic Journal of Medicine October 2008, 75 (10) 739-750;
Frederick R. Singer
Endocrine and Bone Disease Program, John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA
David Geffen School of Medicine at University of California, Los Angeles
David R. Eyre
Ernest M. Burgess Chair of Orthopaedic Investigation, Department of Orthopaedics and Sports Medicine, University of Washington School of Medicine, Seattle
In this issue
Cleveland Clinic Journal of Medicine
Vol. 75, Issue 10
1 Oct 2008
Using biochemical markers of bone turnover in clinical practice
Frederick R. Singer, David R. Eyre
Cleveland Clinic Journal of Medicine Oct 2008, 75 (10) 739-750;
Jump to section
Related Articles
- No related articles found.
Cited By...
- The Use of Type I Collagen Cross-Linked C-Telopeptide (CTX-1) as a Biomarker Associated with the Formation of Periprosthetic Ossifications Following Total Hip Joint Arthroplasty
- Osteoporosis treatment with zoledronic acid in pediatric population at a university hospital in Western Saudi Arabia: A 13-year experience
- Interpreting Adverse Signals in Diabetes Drug Development Programs
- Association between the Healthy Eating Index and bone turnover markers in US postmenopausal women aged >=45 y